Groesbeck Investment Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-18,338
Closed -$320K 83
2025
Q1
$320K Hold
18,338
0.45% 69
2024
Q4
$318K Buy
+18,338
New +$335K 0.41% 73
2024
Q2
Sell
-18,338
Closed -$271K 93
2024
Q1
$271K Buy
+18,338
New +$254K 0.29% 89
2022
Q2
Sell
-18,338
Closed -$273K 103
2022
Q1
$273K Buy
+18,338
New +$251K 0.31% 95
2021
Q4
Sell
-18,338
Closed -$270K 105
2021
Q3
$270K Buy
+18,338
New +$310K 0.31% 94

Other funds holding SBRA

Groesbeck Investment Management's SBRA Position: Q2 2025 in Review

Groesbeck Investment Management sold out of Sabra Healthcare REIT (SBRA) in Q2 2025, closing a stake of 18,338 shares — an estimated $320K sold.

Groesbeck Investment Management first reported a position in SBRA in Q3 2021 and held it in 5 quarters. The position peaked at $320K in Q1 2025. 396 funds tracked by Wall St. Rank hold SBRA as of Q2 2025.

  • Groesbeck Investment Management reported no remaining Sabra Healthcare REIT position as of Q2 2025 after selling out during the quarter.
  • Groesbeck Investment Management sold 18,338 Sabra Healthcare REIT shares in Q2 2025, an estimated $320K.
  • Groesbeck Investment Management first reported a position in Sabra Healthcare REIT in Q3 2021 and held it in 5 quarters.
  • Groesbeck Investment Management's Sabra Healthcare REIT position peaked at $320K in Q1 2025.
  • 396 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2025.

Based on Groesbeck Investment Management's 13F filing for Q2 2025, filed 23 Oct 2025.